natgillin/translations-raw huggingface dataset:
In case of spillage onto, for example table or floor surfaces, remove excess product using paper tissue and clean the area with detergent. 
V primeru razlitja, na primer po mizi ali po tleh, poberite odvečno zdravilo s papirnato brisačo in očistite površino z detergentom.
It is therefore recommended, in accordance with good veterinary practice, that animals of 6 months of age or older and living in areas where a vector exists, should be tested for existing adult heartworm infections before application of the veterinary medicinal product for the prevention of heartworm disease. 
Zato je v skladu z dobro veterinarsko prakso priporočljivo, da so mačke, stare 6 mesecev ali starejše in živijo na področjih, kjer obstaja vektor, testirane glede obstoja infekcij z odraslimi srčnimi glistami, preden apliciramo zdravila za uporabo v veterinarski medicini za preprečevanje bolezni srčne gliste.
Clear colourless to yellow solution. 
Bistra brezbarvna do rumena raztopina.
This product is for topical use and should not be administered orally. 
To zdravilo je za topikalno uporabo in se ne sme dajati peroralno.
It is important to apply the dose as indicated to prevent the animal from licking and ingesting the product. 
Pomembno je, da nanesete odmerek, kot je navedeno, da žival ne more lizati in zaužiti zdravila.
Binding of glutamate-gated chloride channels, which are specific to invertebrates and do not exist in mammals, is considered the main mechanism for the anthelmintic and insecticidal activity. 
Vezava z glutamati nadzorovanih kloridnih kanalov, ki so specifične za nevretenčarje in ne obstajajo pri sesalcih, velja za glavni mehanizem antihelmintične in insekticidne dejavnosti.
The effect on Dirofilaria immitis larvae has been shown to last over a period of 60 days after treatment with the product. 
Učinek na ličinke Dirofilaria immitis dokazano traja preko 60 dni po zdravljenju z zdravilom.
Moxidectin, a semisynthetic derivative of nemadectin, belongs to the milbemycin group of macrocyclic lactones (avermectins being the other) and has parasiticidal activity against a range of internal and external parasites (including ear mites (Otodectes cynotis)). 
Moksidektin, semisintetičen derivat nemadektina, spada v skupino milbemicina makrocikličnih laktonov (avermektini so druga skupina) in ima paraziticidno delovanje proti vrsti notranjih in zunanjih parazitov (vključno z ušesnimi garjami (Otodectes cynotis)).
Fluralaner has a high potency against ticks and fleas by exposure via feeding, i.e. it is systemically active on target parasites. 
Fluralaner ima veliko moč proti klopom in bolham, če so mu izpostavljeni preko hranjenja, to pomeni, da je sistemsko aktiven na ciljne parazite.
In molecular on-target studies on insect GABA receptors of flea and fly, fluralaner is not affected by dieldrin resistance. 
V molekularnih ciljanih študijah na GABA receptorjih bolhe in muhe, fluralanerja ne prizadene odpornost na dieldrin.
If skin contact does occur, wash the affected area immediately with soap and water. 
Če pride do stika s kožo, prizadeto območje takoj sperite z milom in vodo.
Moxidectin lacks substantial efficacy against fleas and ticks. 
Moksidektin nima bistvene učinkovitosti proti bolham in klopom.
The veterinary medicinal product is exclusively indicated when use against ticks or fleas and one or more of the other target parasites is indicated at the same time. 
Zdravilo za uporabo v veterinarski medicini je indicirano izključno tedaj, kadar je indicirana uporaba proti klopom in bolham in proti enemu ali več drugim ciljnim parazitom istočasno.
The pipette is open and ready for application when the breaking of the seal is felt. 
Kapalka je odprta in pripravljena za uporabo, ko začutite da je tesnilo počilo.
People with a sensitive skin or known allergy in general e.g. to other veterinary medicinal products of this type should handle the veterinary medicinal product as well as treated animals with caution. 
Ljudje z občutljivo kožo ali znano alergijo na splošno, npr. na druga zdravila za uporabo v veterinarski medicini tega tipa, morajo z zdravili za uporabo v veterinarski medicini in z zdravljenimi živalmi ravnati previdno.
If skin reactions occur, consult a physician and show them the product packaging. 
Če pride do kožnih reakcij, se posvetujte z zdravnikom in mu pokažite ovojnino zdravila.
This veterinary medicinal product does not require any special temperature storage conditions. 
Za shranjevanje zdravila ni posebnih temperaturnih omejitev.
Macrocyclic lactones including moxidectin have been shown to be substrates for p-glycoprotein. 
Ugotovljeno je, da so makrociklični laktoni, ki vključujejo moksidektin, substrati za p-glikoprotein.
The onset of effect (killing effect) for ticks (I. ricinus) and fleas (C. felis) is within 48 hours after treatment. 
Nastop učinka (ubijanje) za klope (I. ricinus) in bolhe (C. felis) se začne v 48 urah po zdravljenju.
This product can cause eye irritation. 
Zdravilo lahko povzroči draženje oči.
The cap will stay on the pipette; it is not possible to remove it. 
Pokrovček bo ostal na kapalki; ni ga mogoče odstraniti.
The sachets should only be opened immediateley prior to use. 
Vrečice odprite le neposredno pred uporabo.
The need for and frequency of retreatment should be in accordance with the advice of the prescribing veterinarian and take into account the local epidemiological situation. 
Potrebo za ponovno in pogosto zdravljenje mora svetovati veterinar, ki zdravljenje predpiše, upoštevati pa je treba tudi lokalno epidemiološko situacijo.
Step 3: Squeeze the pipette gently and apply the entire contents directly to the cat's skin. 
Tretji korak: Narahlo stiskajte kapalko in nanesite njeno celotno vsebino neposredno na kožo.
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/. 
DATUM ZADNJE ODOBRITVE NAVODIL ZA UPORABO Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) http://www.ema.europa.eu/
Moxidectin is only active on larvae (L3 and L4) of Dirofilaria immitis and not on adult worms. 
Moksidektin deluje samo na ličinke (L3 in L4) Dirofilaria immitis in ne na odrasle parazite.
The safety of the veterinary medicinal product has not been established in pregnant or lactating animals and therefore use in such animals is not recommended. 
Varnost zdravila za uporabo v veterinarski medicini v dobi brejosti in laktacije ni bila dokazana, zato uporaba pri teh živalih ni priporočljiva.
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. 
Bolhe in klopi se morajo pritrditi na gostitelja in se začeti hraniti, da bi bili izpostavljeni zdravilni učinkovini.
For the treatment of tick and flea infestations in cats providing immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. 
Za zdravljenje infestacije s klopi in bolhami pri mačkah, ki zagotavlja takojšnje in trajno ubijanje bolh (Ctenocephalides felis) in klopov (Ixodes ricinus) skozi obdobje 12 tednov.
Ticks and fleas need to start feeding on the host to become exposed to fluralaner; therefore the risk of the transmission of parasite borne diseases cannot be excluded. 
Klopi in bolhe se morajo začeti hraniti na gostitelju , da so izpostavljeni fluralanerju, zato tveganja prenašanja bolezni, ki jih prenašajo paraziti, ni mogoče izključiti.
Keep the pipette in the sachet until use. 
Zdravilo hranite v vrečici do uporabe.
The product contributes towards the control of the environmental flea populations in areas to which treated cats have access. 
Zdravilo prispeva k obvladovanju okoljske populacije bolh na področjih, kamor imajo zdravljene mačke dostop.
Do not use in case of hypersensitivity to the active substance or to any of the excipients. 
Ne uporabite v primerih preobčutljivosti na učinkovino ali na katero koli pomožno snov.
Keep the product in the original packaging until use, in order to prevent children from getting direct access to the product. 
Zdravilo do uporabe shranjujte v originalni ovojnini, da preprečite otrokom neposredni dostop do zdravila.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box 
PODATKI NA ZUNANJI OVOJNINI Kartonska škatla
The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see contraindications, section 4.3). 
Zdravila ne smejo uporabljati osebe s preobčutljivostjo na učinkovino ali katero koli pomožno snov (glejte Kontraindikacije, poglavje 4.3).
For the prevention of heartworm disease in cats that are only temporarily in endemic areas, the product should be applied before the first expected exposure to mosquitoes. 
Za preprečevanje bolezni srčne gliste pri mačkah, ki so začasno na endemičnih področjih, naj se začne pred prvo pričakovano izpostavljenostjo komarjem.
The choice of the additional treatment (monosubstance or combination product) should be determined by the prescribing veterinarian. 
Izbiro glede dodatnega zdravljenja (z eno učinkovino ali kombinacijo učinkovin) naj sprejme veterinar, ki je zdravljenje predpisal.
For the treatment of infections with ear mites (Otodectes cynotis) or the gastrointestinal nematodes T. cati and A. tubaeforme, the need for, and the frequency of, re-treatment as well as the choice of the treatment (monosubstance or combination product) should be evaluated by the prescribing veterinarian. 
Za zdravljenje infestacij z ušesnimi garjami (Otodectes cynotis) ali infekcij z gastrointestinalnima nematodoma T. cati in A. tubaeforme naj potrebo in pogostost ponovnega zdravljenja kakor tudi izbiro zdravljenja (z eno učinkovino ali kombinacijo učinkovin ) oceni veterinar, ki zdravljenje predpiše.
Therefore, during treatment with Bravecto Plus, other products that can inhibit p-glycoprotein (e.g. cyclosporine, ketoconazole, spinosad, verapamil) should only be used concomitantly according to the benefit-risk assessment of the responsible veterinarian. 
Zato se lahko med zdravljenjem z zdravilom Bravecto Plus druga zdravila, ki zavirajo p-glikoprotein (npr. ciklosporin, ketokonazol, spinosad, verapamil), uporabljajo sočasno samo v skladu z oceno razmerja korist-tveganje odgovornega veterinarja.
Hypersensitivity reactions to another veterinary medicinal product containing fluralaner and the same excipients as Bravecto Plus have been reported in a small number of people. 
Pri majhni skupini ljudi so poročali o preobčutljivostnih reakcijah pri drugem zdravilu za uporabo v veterinarski medicini, ki vsebuje fluralaner, in enake pomožne snovi, kot zdravilo Bravecto Plus.
Fluralaner is slowly eliminated from plasma (t1/2 = 15 days) and excreted in faeces and to a very low extent in urine. 
Fluralaner se počasi izloča iz plazme (t1/2 = 15 dni) v fecesu in v zelo majhni količini v urin.
Cats in areas endemic for heartworm, or cats which have travelled to endemic areas, may be infected with adult heartworms. 
Mačke na področjih, ki so endemična za srčne gliste ali mačke, ki so potovale na endemična področja, so lahko okužene z odraslimi srčnimi glistami.
The following table defines the size of pipette to be used according to the body weight of the cat (corresponding to a dose of 40-94 mg fluralaner/kg body weight and 2-4.7 mg moxidectin/kg body weight): 
Spodnja tabela določa velikost kapalke, ki jo je treba uporabiti glede na telesno maso mačke (ki odgovarja odmerku 40-94 mg fluralanerja in 2-4,7 mg moksidektina /kg telesne mase ):
For cats more than 12.5 kg, use a combination of two pipettes that most closely matches the body weight. 
Za mačke s telesno maso nad 12,5 kg uporabite kombinacijo dveh kapalk, ki se najbolj približa telesni masi.
In case of contact with the eyes, immediately rinse thoroughly with water. 
V kolikor pride zdravilo v stik z očmi, ga takoj temeljito sperite z vodo.
Therefore prior to application of Bravecto Plus for the concurrent prevention of infection with adult D. immitis, the advice provided in section 4.4 should be considered. 
Zato je treba pred uporabo zdravila Bravecto Plus za sočasno preventivo infekcije z odraslimi D. immitis upoštevati nasvet iz poglavja 4.4.
Fluralaner is a potent inhibitor of parts of the arthropod nervous system by acting antagonistically on ligand-gated chloride channels (GABA-receptor and glutamate-receptor). 
Fluralener je močan inhibitor delov živčnega sistema artropodov s svojim antagonističnim delovanjem na GABA receptor in na receptor glutamata.
Rotate cap (cap cannot be removed). 
Zavrtite zaporko (zaporke ni mogoče odstraniti).
Each ml of solution contains 280 mg fluralaner and 14 mg moxidectin. 
1 ml raztopine vsebuje fluralaner 280 mg in moksidektin 14 mg.
Unit dose pipette made of laminated aluminium/polypropylene foil closed with a high-density polyethylene (HDPE) cap and packed in a laminated aluminium foil sachet. 
Merilna kapalka iz laminirane aluminijasto/polipropilenske folije zaprta s HDPE zaporko in pakirana v vrečico iz laminirane aluminijaste folije.
Oral uptake of the product at the maximum recommended dose of 93 mg fluralaner + 4.65 mg moxidectin/kg body weight induced some self-limiting salivation or single incidences of vomiting immediately after administration. 
Peroralno zaužitje zdravila v največjem priporočenem odmerku 93 mg fluralanerja + 4,65 mg moksidektina/kg telesne mase je sprožilo slinjenje, ki je samo po sebi prenehalo, ali posamezne primere bruhanja takoj po dajanju.
Each pipette delivers: 
Vsaka kapalka vsebuje:
For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. 
Za mačke, ki imajo ali so v nevarnosti, da zbolijo zaradi mešanih parazitarnih infestacij s klopi ali bolhami in ušesnimi garjami, ter infekcij z gastrointestinalnimi nematodi ali srčnimi glistami.
For the treatment of infestations with ear mites (Otodectes cynotis). 
Za zdravljenje infestacij z ušesnimi garjami (Otodectes cynotis).
Moxidectin is slowly eliminated from plasma (t1/2 = 26 days) and excreted in faeces and to a very low extent in urine. 
Moksidektin se počasi izloča iz plazme (t1/2 = 26 dni) v fecesu in v zelo majhni količini v urin.
The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see contraindications, section 5). 
Zdravila ne smejo uporabljati osebe s preobčutljivostjo za učinkovino ali katerokoli pomožno snov (glejte Kontraindikacije, poglavje 5).
Cats in areas endemic for heartworm (or those which have travelled to endemic areas) may be infected with adult heartworms. 
Mačke na področjih, ki so endemična za srčne gliste (ali mačke, ki so potovala na taka področja), so lahko okužene z odraslimi srčnimi glistami.
Step 1: Immediately before use, open the sachet and remove the pipette. 
Prvi korak: Neposredno pred uporabo odprite vrečko in izvlecite kapalko.
Put on gloves. 
Nataknite si rokavice.
Step 2: The cat should be standing or lying with its back horizontal for easy application. 
Drugi korak: Žival naj med dajanjem stoji ali leži, hrbet pa naj bo vodoraven.
Seek further veterinary examination (i.e. otoscopy) 28 days after treatment to determine whether there is re-infestation requiring additional treatment. 
28 dni po dajanju zdravila naj veterinar opravi pregled (npr. otoskopijo) in odloči ali je prišlo do ponovne infestacije, ki zahteva dodatno zdravljenje.
In in vitro bio-assays, fluralaner is not affected by proven field resistances against amidines (tick), organophosphates (tick), cyclodienes (tick, flea), phenylpyrazoles (tick, flea), benzophenyl ureas (tick), and pyrethroids (tick). 
V in vitro biotestih na fluralaner ne vpliva dokazana odpornost na terenu na amidine (klop), organofosfate (klop), ciklodiene (klop, bolha), fenilpirazole (klop, bolha), benzofenil uree (klop) in piretroide (klop).
EU/2/18/224/001 (112.5 mg + 5.6 mg, 1 pipette) EU/2/18/224/002 (112.5 mg + 5.6 mg, 2 pipettes) EU/2/18/224/003 (250 mg + 12.5 mg, 1 pipette) EU/2/18/224/004 (250 mg + 12.5 mg, 2 pipettes) EU/2/18/224/005 (500 mg + 25 mg, 1 pipette) EU/2/18/224/006 (500 mg + 25 mg, 2 pipettes) 
EU/2/18/224/001 (112,5 mg + 5,6 mg, 1 kapalka) EU/2/18/224/002 (112,5 mg + 5,6 mg, 2 kapalki) EU/2/18/224/003 (250 mg + 12,5 mg, 1 kapalka) EU/2/18/224/004 (250 mg + 12,5 mg, 2 kapalki) EU/2/18/224/005 (500 mg + 25 mg, 1 kapalka) EU/2/18/224/006 (500 mg + 25 mg, 2 kapalki)
For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma tubaeforme). 
Za zdravljenje infekcij s črevesnimi glistami (ličinke 4. stopnje, nezrele odrasle in odrasle oblike Toxocara cati) in trakuljami (ličinke 4. stopnje, nezrele odrasle in odrasle oblike Ancylostoma tubaeforme).
The product is highly flammable. 
To zdravilo je zelo vnetljivo.
Therefore prior to application of Bravecto Plus for the concurrent prevention of infection with adult D. immitis, the advice provided in section 12 should be considered. 
Zato je treba pred uporabo zdravila Bravecto Plus za sočasno preventivo okužbe z odraslimi D. immitis upoštevati nasvet iz poglavja 12.
In case of accidental ingestion, seek medical advice and show the package leaflet or the label to the physician. 
V primeru nenamernega zaužitja poiščite zdravniški nasvet in pokažite zdravniku navodilo za uporabo ali nalepko.
Cap does not come off. 
Pokrovček se ne odstrani.
Bravecto Plus spot-on solution is available in three pipette sizes. 
Zdravilo Bravecto Plus solucija za kožni nanos je na voljo v treh velikostih kapalk.
Name and address of the manufacturer(s) responsible for batch release 
Ime in naslov proizvajalca (proizvajalcev) zdravila, odgovornega za sproščanje serij
Read package leaflet for full user safety information. 
Pri rokovanju in nanašanju zdravila uporabljajte rokavice Za popolne varnostne informacije za uporabnika preberite navodilo za uporabo.
The product binds to skin and may also bind to surfaces after spillage of the product. 
Zdravilo se veže na kožo in se v primeru razlitja lahko veže na površino, kjer se je zdravilo razlilo.
The pharmacokinetic profiles of fluralaner and moxidectin are not affected by co-administration. 
Na farmakokinetični profil fluralanerja in moksidektina sočasno dajanje ne vpliva.
MANUFACTURER'S BATCH NUMBER 
PROIZVAJALČEVA ŠTEVILKA SERIJE Lot:{številka}
For the concurrent treatment of infections with ear mites (Otodectes cynotis), a single dose of the product should be applied. 
Za sočasno zdravljenje infestacij z ušesnimi garjami (Otodectes cynotis) je potrebno dati en sam odmerek zdravila.
For the concurrent treatment of infections with the gastrointestinal nematodes T. cati and A. tubaeforme, a single dose of the product should be applied. 
Za sočasno zdravljenje okužb z gastrointestinalnimi nematodi T. cati in A. tubaeforme je treba dati en sam odmerek zdravila.
Special precautions to be taken by the person administering the veterinary medicinal product to animals: 
Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo za uporabo v veterinarski medicini:
for small cats 1.2 - 2.8kg for medium-sized cats >2.8 - 6.25 kg for large cats >6.25 - 12.5 kg 
za majhne mačke 1,2 - 2,8 kg za srednje velike mačke >2,8 - 6,25 kg za velike mačke >6,25 - 12,5 kg
Fluralaner is readily systemically absorbed from the topical administration site, reaching maximum concentrations in plasma between 3 and 21 days after administration. 
Po topikalnem dajanju se fluralaner zlahka absorbira iz mesta nanosa in doseže maksimalno koncentracijo v krvni plazmi med 3 in 21 dnevi po dajanju.
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents, endectocides, milbemycins. 
Farmakoterapevtska skupina: antiparazitiki, insekticidi in repelenti, endektocidi, milbemicini Oznaka ATCvet: QP54AB52
In order to avoid contact, disposable protective gloves obtained with this product at the point of sale must be worn when handling and administering the product. 
Da bi se izognili stiku, je pri rokovanju in dajanju zdravila treba nositi zaščitne rokavice za enkratno uporabo, ki ste jih prejeli skupaj s tem zdravilom na prodajnem mestu.
It is efficacious against ticks (Ixodes ricinus), fleas (Ctenocephalides felis) and ear mites (Otodectes cynotis) on the cat. 
), bolham (Ctenocephalides felis) in ušesnim garjam (Otodectes cynotis) pri mačkah.
Marketing authorisation holder: Intervet International B. V. Wim de Körverstraat 35 
Imetnik dovoljenja za promet z zdravilom: Intervet International B. V.
Within each weight band, the content of one whole pipette should be used. 
Za vsako stopnjo telesne mase je treba porabiti eno polno kapalko.
Do not use this veterinary medicinal product after the expiry date stated on the packaging after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na pretisnem omoti za EXP. Rok uporabnosti zdravila se nanaša na zadnji dan v navedenem mesecu.
Moxidectin is readily systemically absorbed from the topical administration site, reaching maximum concentrations in plasma between 1 and 5 days after administration. 
Moksidektin se po topikalnem dajanju zlahka absorbira iz mesta nanosa in doseže maksimalno koncentracijo v krvni plazmi med 1 in 5 dnevi po dajanju.
The following other adverse reactions were uncommonly observed in clinical trials shortly after administration: dyspnoea after licking the application site, hypersalivation, emesis, haematemesis, diarrhoea, lethargy, pyrexia, tachypnoea, mydriasis. 
Kratek čas po dajanju zdravila so bili občasno opaženi naslednji neželeni učinki: dispneja po lizanju mesta nanosa, povečano slinjenje, emeza, hematemeza, diareja, letargija, pireksija, tahipneja, midriaza.
The pipette should be held by the base or by the upper rigid portion below the cap in an upright position (tip up) for opening it. 
Merilno kapalko je treba držati za njeno bazo ali za trdi del pod zaporko v pokončnem položaju za odpiranje.
Skin rashes, tingling or numbness have been reported in a small number of individuals after skin contact. 
Po stiku s kožo so pri manjšem številu posameznikov poročali o izpuščajih, mravljinčenju ali otrplosti kože.
Avoid contact with skin, mouth and/or eye. Do not contact the application site until it is no longer noticeable. 
Izogibajte se stiku s kožo, usti in/ali očmi.
The pipettes should be kept in the sachets to prevent solvent loss or moisture uptake. 
Merilne kapalke hranite v vrečicah, da se prepreči izgubo vehikla in da se ne navzame vlage.
Butylhydroxytoluene Dimethylacetamide Glycofurol 
6.1 Seznam pomožnih snovi butilhidroksitoluen dimetilacetamid glikofurol dietiltoluamid (DEET) aceton
Place the pipette tip on the base of the skull of the cat. 
Nastavite vrh kapalke na kožo na spodnji del lobanje.
No adverse reactions were observed following topical administration to kittens aged 9-13 weeks and weighing 0.9-1.9 kg treated with overdoses of up to 5 times the maximum recommended dose (93 mg fluralaner + 4.65 mg moxidectin, 279 mg fluralaner + 13.95 mg moxidectin and 465 mg fluralaner + 23.25 mg moxidectin/kg body weight) on three occasions at shorter intervals than recommended (8week intervals). 
Ko so mačkam, starim 9-13 tednov in težkim 0,9-1,9 kg, dajali topikalno do 5 krat večje odmerke od največjega priporočenega odmerka (93 mg fluralanerja + 4,65 mg moksidektina, 279 mg fluralanerja +13,95 mg moksidektina in 465 mg fluralanerja + 23,25 mg moksidektina/ kg telesne mase ) trikrat v krajših razmikih, kot je priporočeno (8-tedenski razmiki), niso opazili nobenih neželenih učinkov.
Shelf life of the veterinary medicinal product as packaged for sale: 2 years. 
Rok uporabnosti zdravila v pakiranju za prodajo: 2 leti 6.4 Posebna navodila za shranjevanje
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Pipette 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
112.5 mg fluralaner / 5.6 mg moxidectin 250 mg fluralaner / 12.5 mg moxidectin 500 mg fluralaner / 25 mg moxidectin 
KOLIČINA UČINKOVINE 112,5 fluralaner / 5,6 mg moksidektin 250 mg fluralaner /12,5 mg moksidektin 500 mg fluralaner / 25 mg moksidektin